valsartan has been researched along with Carcinoma, Epidermoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Tchernev, G | 1 |
Han, Q; Lei, J; Liao, YD; Wang, ZH; Xu, H; Zhang, YY | 1 |
2 other study(ies) available for valsartan and Carcinoma, Epidermoid
Article | Year |
---|---|
NITROSOGENESIS LESSONS FROM DERMATOLOGISTS-NITROSAMINES/ NDSRIS CONTAMINATION OF THE POLIMEDICATION IN POLIMORBID PATIENTS AS THE MOST POWERFUL SKIN CANCER INDUCTOR: DOUBLE HATCHET FLAP FOR SCC OF THE SCALP OCCURRING DURING TREATMENT WITH VALSARTAN/ HYDRO
Topics: Aged, 80 and over; Carcinogens; Carcinoma, Squamous Cell; Dermatologists; Humans; Hydrochlorothiazide; Nitrosamines; Quality of Life; Scalp; Skin Neoplasms; Valsartan | 2023 |
[Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Staging; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2007 |